Chart Update: Abiomed ABMD Rewards the Patient

Traders who were patient with the position can now focus on that 13-week SMA as a trailing stop or even consider the 20-week SMA. Selling at either will still lock in some attractive gains from a low $140s entry.

At $20 or Lower, Control4 CTRL Is a Buy

The recent highs have created resistance in the $20-to-$21 area. The consistent higher lows with the same highs has formed a very tight ascending triangle and there are two approaches to consider for entry.